Cargando…

Recent Insights into the Biomarkers, Molecular Targets and Mechanisms of Non-Alcoholic Steatohepatitis-Driven Hepatocarcinogenesis

SIMPLE SUMMARY: This review is focused on the research recently published in the field of non-alcoholic fatty liver disease (NAFLD) or metabolic dysfunction-associated steatotic liver disease (MASLD), and steatohepatitis (NASH)-associated liver cancer. We aimed to highlight recent omics research on...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kakehashi, Anna, Suzuki, Shugo, Wanibuchi, Hideki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10527326/ https://www.ncbi.nlm.nih.gov/pubmed/37760534 http://dx.doi.org/10.3390/cancers15184566

Ejemplares similares

Cache Domain Containing 1 Is a Novel Marker of Non-Alcoholic Steatohepatitis-Associated Hepatocarcinogenesis
por: Kakehashi, Anna, et al.
Publicado: (2021)

Canopy Homolog 2 as a Novel Molecular Target in Hepatocarcinogenesis
por: Kakehashi, Anna, et al.
Publicado: (2021)

Accumulation of 8-hydroxydeoxyguanosine, L-arginine and Glucose Metabolites by Liver Tumor Cells Are the Important Characteristic Features of Metabolic Syndrome and Non-Alcoholic Steatohepatitis-Associated Hepatocarcinogenesis
por: Kakehashi, Anna, et al.
Publicado: (2020)

Proteome Characteristics of Non-Alcoholic Steatohepatitis Liver Tissue and Associated Hepatocellular Carcinomas
por: Kakehashi, Anna, et al.
Publicado: (2017)

mTOR Activation in Liver Tumors Is Associated with Metabolic Syndrome and Non-Alcoholic Steatohepatitis in Both Mouse Models and Humans
por: Okuno, Takahiro, et al.
Publicado: (2018)

Valerian Inhibits Rat Hepatocarcinogenesis by Activating GABA(A) Receptor-Mediated Signaling
por: Kakehashi, Anna, et al.
Publicado: (2014)

MUTYH is associated with hepatocarcinogenesis in a non-alcoholic steatohepatitis mouse model
por: Sakamoto, Hiroki, et al.
Publicado: (2021)

Silencing of microRNA-122 is an early event during hepatocarcinogenesis from non-alcoholic steatohepatitis
por: Takaki, Yoko, et al.
Publicado: (2014)

Role of γ-H2AX as a biomarker for detection of bladder carcinogens in F344 rats
por: Suzuki, Shugo, et al.
Publicado: (2020)

Characteristic Upregulation of Glucose-Regulated Protein 78 in an Early Lesion Negative for Hitherto Established Cytochemical Markers in Rat Hepatocarcinogenesis
por: Sukata, Tokuo, et al.
Publicado: (2009)

Alcohol and hepatocarcinogenesis
por: Taniai, Makiko
Publicado: (2020)

Response biomarkers of inhalation exposure to cigarette smoke in the mouse lung
por: Suzuki, Shugo, et al.
Publicado: (2022)

Antioxidative Self-Assembling Nanoparticles Attenuate the Development of Steatohepatitis and Inhibit Hepatocarcinogenesis in Mice
por: Watahiki, Takahisa, et al.
Publicado: (2022)

Molecular Targets in Hepatocarcinogenesis and Implications for Therapy
por: Wu, Meng-Yu, et al.
Publicado: (2018)

Novel Molecular Mechanisms in the Development of Non-Alcoholic Steatohepatitis
por: Povero, Davide, et al.
Publicado: (2016)

Recent Insights Into the Multiple Pathways Driving Non-alcoholic Steatohepatitis-Derived Hepatocellular Carcinoma
por: Takakura, Kazuki, et al.
Publicado: (2019)

Chemopreventive Effects of Coumaperine from Pepper on the Initiation Stage of Chemical Hepatocarcinogenesis in the Rat
por: Kitano, Mitsuaki, et al.
Publicado: (2000)

Recent advances in understanding/management of non-alcoholic steatohepatitis
por: Pacana, Tommy, et al.
Publicado: (2015)

Gut insulin action protects from hepatocarcinogenesis in diabetic mice comorbid with nonalcoholic steatohepatitis
por: Soeda, Kotaro, et al.
Publicado: (2023)

Genome-wide DNA methylation analysis during non-alcoholic steatohepatitis-related multistage hepatocarcinogenesis: comparison with hepatitis virus-related carcinogenesis
por: Kuramoto, Junko, et al.
Publicado: (2017)

S‐Methylcysteine and Cysteine Are Inhibitors of Induction of Glutathione S‐Transferase Placental Form‐positive Foci during Initiation and Promotion Phases of Rat Hepatocarcinogenesis
por: Takada, Nobuyasu, et al.
Publicado: (1997)

Molecular Mechanisms and New Treatment Strategies for Non-Alcoholic Steatohepatitis (NASH)
por: Takaki, Akinobu, et al.
Publicado: (2014)

Chronic Inflammation in Non-Alcoholic Steatohepatitis: Molecular Mechanisms and Therapeutic Strategies
por: Luci, Carmelo, et al.
Publicado: (2020)

The carbonic anhydrase inhibitor acetazolamide inhibits urinary bladder cancers via suppression of β‐catenin signaling
por: Matsue, Taisuke, et al.
Publicado: (2022)

CD44 variant 9 is a potential biomarker of tumor initiating cells predicting survival outcome in hepatitis C virus‐positive patients with resected hepatocellular carcinoma
por: Kakehashi, Anna, et al.
Publicado: (2016)

Pathology-MRI Correlation of Hepatocarcinogenesis: Recent Update
por: Huh, Jimi, et al.
Publicado: (2015)

Diagnostic performance of circulating biomarkers for non-alcoholic steatohepatitis
por: Sanyal, Arun J., et al.
Publicado: (2023)

Immunological Mechanisms in the Pathophysiology of Non-Alcoholic Steatohepatitis
por: Vonghia, Luisa, et al.
Publicado: (2013)

Mechanisms of ductular reaction in non-alcoholic steatohepatitis
por: Chen, Yue, et al.
Publicado: (2022)

Oxidative Stress in the Carcinogenicity of Chemical Carcinogens
por: Kakehashi, Anna, et al.
Publicado: (2013)

Network Pharmacology and Molecular Docking Study on the Multi-Target Mechanisms of Aloe vera for Non-Alcoholic Steatohepatitis Treatment
por: Nguyen, Tan Khanh, et al.
Publicado: (2022)

DNA Methylation Aberrations in Dimethylarsinic Acid-Induced Bladder Carcinogenesis
por: Yamamoto, Tomoki, et al.
Publicado: (2023)

A novel model of non-alcoholic steatohepatitis with fibrosis and carcinogenesis in connexin 32 dominant-negative transgenic rats
por: Naiki-Ito, Aya, et al.
Publicado: (2020)

Promotion of Rat Hepatocarcinogenesis by Dimethylarsinic Acid: Association with Elevated Ornithine Decarboxylase Activity and Formation of 8‐Hydroxydeoxyguanosine in the Liver
por: Wanibuchi, Hideki, et al.
Publicado: (1997)

Combined alcoholic and non-alcoholic steatohepatitis
por: Ntandja Wandji, Line Carolle, et al.
Publicado: (2020)

Recent Insight into the Role of Fibrosis in Nonalcoholic Steatohepatitis-Related Hepatocellular Carcinoma
por: Sircana, Antonio, et al.
Publicado: (2019)

The Role of Fructose in Non-Alcoholic Steatohepatitis: Old Relationship and New Insights
por: Federico, Alessandro, et al.
Publicado: (2021)

Evaluation of the Subchronic Toxicity of Dietary Administered Equisetum arvense in F344 Rats
por: Tago, Yoshiyuki, et al.
Publicado: (2010)

Cytokeratin 8/18 overexpression and complex formation as an indicator of GST-P positive foci transformation into hepatocellular carcinomas
por: Kakehashi, Anna, et al.
Publicado: (2009)

The SGLT2 Inhibitor Canagliflozin Prevents Carcinogenesis in a Mouse Model of Diabetes and Non-Alcoholic Steatohepatitis-Related Hepatocarcinogenesis: Association with SGLT2 Expression in Hepatocellular Carcinoma
por: Jojima, Teruo, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_1eipnrg0v49ti1nod4t6jlqqp1